Federal grand jury subpoenas from N.D. Texas to hospitals for transgender minors' records

Enforcement/investigationFDA

Date
Actor
U.S. Attorney's Office, N.D. Tex. (with FDA); DOJ
Agency
Food and Drug Administration (FDA)
Type
Enforcement/investigation
Section
DEPARTMENT OF JUSTICE

Summary

After its administrative-subpoena losses, DOJ escalated to criminal process: grand jury subpoenas dated May 6, 2026, issued out of the Northern District of Texas, were served on hospitals including NYU Langone Health (received May 7, 2026) and Stanford Medicine's Lucile Packard Children's Hospital, demanding patient-specific, patient-identifiable information about transgender minors receiving gender-affirming care, with production to an FDA agent in Kansas City. The subpoenas signal a purported criminal investigation into federal healthcare offenses connected to the care.

Status

Blocked as to New York hospitals (S.D.N.Y. TRO June 24, 2026, and preliminary injunction in Coe v. Blanche) and Stanford (N.D. Cal. preliminary injunction July 2, 2026); DOJ appeals pending; no indictment of any provider as of August 2026.

As recorded in the data of . Check the sources for anything newer.

Related litigation

Sources